[1]
Bettiol, A., Bolcato, J., Pirolo, R., Franchin, G., Deambrosis, P., Giusti, P. and Chinellato, A. 2016. Prevalence, Costs and Consequences of “Manovra AIFA” for ICS-LABA Treatment in Patients with Asthma or COPD: A Real-Practice Analysis: L’impatto della manovra AIFA sui costi di trattamento con ICS-LABA: focus sui pazienti affetti da asma e BPCO. Global & Regional Health Technology Assessment. 3, 3 (Oct. 2016), 115–124. DOI:https://doi.org/10.33393/grhta.2016.417.